ArticleFrontiers in immunology2026

Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor pneumonitis in advanced NSCLC: a multicenter multimodal study.

Lei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.